Bourne Partners

Bourne Partners is an investment banking firm founded in 2000 that focuses exclusively on healthcare and pharmaceutical sectors. Based in Charlotte, North Carolina, the firm has completed over $10 billion in transactions over its 25-year history, serving clients globally across pharma, pharma services, and healthcare services sectors.

The firm's core services include mergers and acquisitions advisory, with particular depth in behavioral health, pharmacy services, clinical research organizations, and value-based care transitions. The team comprises seasoned investment bankers with operational healthcare experience, led by founder Banks Bourne and supported by managing directors who head specialized practice areas including healthcare services, pharma investment banking, and private equity sponsor coverage.

Bourne Partners also produces proprietary research on healthcare sectors, including detailed market analyses such as their 2025 Autism Therapy Market Update. The firm maintains relationships with strategic buyers and private equity investors across the healthcare ecosystem, positioning them to advise on complex healthcare transactions.

Choose Bourne Partners when selling a pharmaceutical, pharma services, or healthcare services company where sector-specific expertise and buyer relationships are critical to maximizing value. The firm excels at navigating complex healthcare transactions involving regulatory considerations, payer dynamics, and operational healthcare nuances that generalist investment banks may overlook.

Expect a senior-level engagement with experienced bankers who understand both the financial and operational aspects of healthcare businesses. The firm's research capabilities and market intelligence provide strategic context beyond traditional deal execution, particularly valuable for businesses in evolving sectors like behavioral health and value-based care.

Bourne Partners operates exclusively within healthcare, with 100% of its business focused on pharmaceutical and healthcare services sectors. The firm demonstrates deep healthcare expertise through specialized practice areas in behavioral health (including autism therapy providers), pharmacy services, clinical CROs, managed care, and post-acute care.

Their healthcare focus extends to understanding complex reimbursement dynamics, including Medicaid and value-based care transitions, as evidenced by their detailed research on autism therapy market shifts from fee-for-service to value-based reimbursement models. The firm advises healthcare clients on navigating regulatory environments, payer relationships, and sector-specific operational challenges that impact transaction valuations.

The ideal client is a pharmaceutical, pharma services, or healthcare services company with revenues between $20 million and $500 million considering a sale or seeking growth capital. Companies in behavioral health, clinical research, pharmacy services, or post-acute care with established operations and seeking strategic or private equity buyers will benefit most from Bourne Partners' sector expertise and established buyer relationships.